[ESMO Conference 2004. Ibandronate in the treatment of bone metastasis].
Longo
Flavia
F
Servizio di Oncologia Medica, Policlinico Umberto I, Roma.
Mansueto
Giovanni
G
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control
D000700:Analgesics; D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077557:Ibandronic Acid